Convexity Labs

AVO

Convexity Analyst · AVO
Buymedium confidenceTactical · no named thesis
Generated Jun 21, 2026

Analyst Note: AVO (Mission Produce, Inc.)

Date: 2026-06-13 Current Price: $11.49

1. Structural Readiness

State: Context-Only Conservative Entry: — (Pending breakout confirmation) Current Price: $11.49 Extension:ATR at Breakout:ATR Current: 4.8% (High) Pivot Strength:

Structural Analysis:

2. Thesis Layer

Thesis Classification: Tactical / Setup-Led Secular Exposure: None Named

At this date, there is no named secular thesis driving this specific setup. This is a tactical, setup-led name. The conviction must be derived strictly from the quality of the structural setup (the forming coil) and the immediate business fundamentals disclosed in the recent earnings cycle. We do not invent a macro thesis; we judge the name on its ability to execute its current operational plan and the technical readiness of the price structure.

3. Business Overview

Company Profile: Mission Produce, Inc. is a world leader in sourcing, producing, growing, and distributing Hass avocados, serving retail, wholesale, and foodservice customers globally. The company operates through two distinct segments: International Farming and Marketing and Distribution. Beyond core fruit distribution, the firm provides value-added services including fruit ripening, bagging, custom packaging, and logistical management.

Key Operational Updates (Source: Earnings Transcript 2026-06-08):

  • Production Volume: The company expects exportable avocado production from its own farms in Peru to reach all-time highs of 120 to 130 million pounds for the current season, up from 105 million pounds in the 2025 harvest. Sales of this own production are weighted to the fiscal fourth quarter.
  • Acquisition Integration: On May 28, 2026, the company consummated the acquisition of 100% of the outstanding common stock of Calavo. Calavo is a leading provider of fresh avocados, tomatoes, papayas, and value-added prepared foods (guacamole, salsas).
  • Financial Guidance:
  • Q3 Adjusted EBITDA: Expected in the range of $28 to $32 million, including partial quarter contribution from Calavo.
  • H2 Adjusted EBITDA: Expected in the range of $84 to $88 million, driven by a full quarter of Calavo results, higher blueberry yields, and improving avocado margins.
  • Synergies: Management expects a minimum of $25 million in annualized cost synergies achievable within 18 months of the Calavo close, with meaningful upside potential.
  • Market Dynamics: U.S. avocado consumption reached new highs, increasing in strong double digits year-over-year, with 1.6 million new households entering the category.
  • Pricing Environment: Pricing is expected to be lower year-over-year by approximately 15% compared to the $1.75/lb average in Q3 FY2025, though this reduction is smaller than the first half of the fiscal year.
  • Customer Concentration: Sales to the top 10 customers amounted to approximately 67% of net sales for the year ended October 31, 2025.

4. Archetype and Conviction

Archetype: Quality Compounder (with Cyclical Recovery characteristics) Rationale: The name fits the Quality Compounder archetype due to its dominant market position, vertical integration (owning farms in Peru), and the strategic accretion of Calavo, which expands its value-added capabilities. The business model leverages a long-term secular trend in avocado consumption (penetration gains) while managing cyclical pricing pressures.

Conviction Stack:

  • Thesis Strength: Moderate. The lack of a named macro thesis limits the "story" to tactical execution, but the operational data is robust.
  • Evidence Quality: High. The evidence base is dense with specific, quantitative guidance from the June 8, 2026 earnings call (production volumes, EBITDA ranges, synergy targets).
  • Structural Quality: Moderate/High. The ATR of 4.8% indicates healthy volatility suitable for a setup, but the "Forming" state means the structural confirmation is pending.
  • Setup Readiness: Partial. The coil is forming, not confirmed. The setup is live but requires a breakout to be fully actionable.
  • Valuation Context: The financial spine indicates a forward consensus EPS of $0.615 for FY1 and $0.82 for FY2. The current price of $11.49 implies a forward P/E of approximately 18.7x for FY1 and 14.0x for FY2. Given the guidance for EBITDA expansion and synergy capture, the valuation appears to be pricing in a steady recovery rather than a hyper-growth explosion.

5. Invalidations, Strengths, and Gaps

What Would Strengthen the Case:

  • Synergy Realization: Evidence that the $25M synergy target is being met ahead of the 18-month timeline.
  • Margin Expansion: Confirmation that "improving avocado margins" (mentioned in H2 guidance) are materializing despite the 15% pricing headwind.

What Would Invalidate the Case:

  • Operational Disruption: Any material delay in the integration of Calavo or a significant shortfall in the 120-130 million pound Peru harvest target.
  • Customer Concentration Risk: A significant loss of top-tier customers (given the 67% concentration) would threaten revenue stability.

Evidence Gaps:

  • Debt Structure Details: While an amended credit agreement exists (E12), specific leverage ratios or covenant terms post-acquisition are not detailed in the provided snippets.
  • Blueberry Yield Specifics: The guidance mentions "higher blueberry yields" as a driver, but specific volume or margin impact data is not provided.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: Medium Key evidence: 1) Peru exportable production guidance of 120-130M lbs (all-time high); 2) Calavo acquisition integration driving H2 EBITDA to $84-88M range; 3) $25M annualized synergy target achievable within 18 months. Key risks: 1) 15% YoY pricing headwind impacting top-line growth; 2) High customer concentration (67% to top 10); 3) Setup remains in "Forming" state pending breakout confirmation. Sizing hint: Position size should reflect the "Forming" status; smaller than a confirmed breakout, larger than a speculative long-only. Expected path: Management expects EBITDA expansion in H2 driven by full Calavo integration and synergy capture; price likely to consolidate near current levels until a structural breakout occurs. Expected horizon: 3 to 6 months for setup confirmation and synergy realization.

Loading chart...
Exhibit 1: AVO daily candlestick — no active setup overlay.

Source-backed evidence anchors and catalysts land once Convexity finishes coverage for AVO.

Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.

Value picture unavailable — no financial spine on file for AVO.

Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.

Coverage: